Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Pharmaceuticals
Trading - Medium / Small
9,209 Cr
High Risk
275.4
35.9
2.1
73.2
850.00
516.50
Sales CAGR
1Y
39.71%
3Y
47.41%
5Y
37.80%
10Y
—
Profit CAGR
1Y
199.55%
3Y
100.41%
5Y
73.77%
10Y
—
ROE
TTM
—
3Y
32.77%
5Y
33.03%
10Y
—
ROCE
TTM
—
3Y
44.01%
5Y
44.66%
10Y
—
Bearish
4
Neutral
4
Bullish
6
Bearish
24
Neutral
16
Bullish
6
Bearish
20
Neutral
12
Bullish
0
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Market Cap
₹ 9,209 Cr
P/E
275.41
Performance
STEADY PERFORMER
Valuation
OVERVALUED
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Press Release
1 day ago
Publication of Case Studies on Ayurvedic Treatments
Jeena Sikho Lifecare Limited has published several case studies in the Ayurvidya Adhyan journal, highlighting advancements in Ayurvedic research and its applications in managing chronic diseases.
Publication Announcement
4 days ago
Publication of Ayurvedic Case Studies
Jeena Sikho Lifecare Limited announced the publication of multiple Ayurvedic case studies that highlight the efficacy of Ayurvedic therapies in managing chronic kidney disease and diabetes.
Corporate Action
6 days ago
Approval for ESOP Listing
Jeena Sikho Lifecare Limited received in-principle approval from NSE and BSE for listing a maximum of 250,000 equity shares under its Employees Stock Option Scheme, 2025.